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The gene Par-4 (Prostate Apoptosis Response 4) was originally identified in prostate
cancer cells undergoing apoptosis and its product Par-4 showed cancer specific pro-
apoptotic activity. Particularly, the SAC domain of Par-4 (SAC-Par-4) selectively kills
cancer cells leaving normal cells unaffected. The therapeutic significance of bioactive
SAC-Par-4 is enormous in cancer biology; however, its large scale production is still
a matter of concern. Here we report the production of SAC-Par-4-GFP fusion protein
coupled to translational enhancer sequence (5′ AMV) and apoplast signal peptide (aTP)
in transgenic Nicotiana tabacum cv. Samsun NN plants under the control of a unique
recombinant promoter M24. Transgene integration was confirmed by genomic DNA
PCR, Southern and Northern blotting, Real-time PCR, and Nuclear run-on assays.
Results of Western blot analysis and ELISA confirmed expression of recombinant SAC-
Par-4-GFP protein and it was as high as 0.15% of total soluble protein. In addition,
we found that targeting of plant recombinant SAC-Par-4-GFP to the apoplast and
endoplasmic reticulum (ER) was essential for the stability of plant recombinant protein in
comparison to the bacterial derived SAC-Par-4. Deglycosylation analysis demonstrated
that ER-targeted SAC-Par-4-GFP-SEKDEL undergoes O-linked glycosylation unlike
apoplast-targeted SAC-Par-4-GFP. Furthermore, various in vitro studies like mammalian
cells proliferation assay (MTT), apoptosis induction assays, and NF-κB suppression
suggested the cytotoxic and apoptotic properties of plant-derived SAC-Par-4-GFP
against multiple prostate cancer cell lines. Additionally, pre-treatment of MAT-LyLu
prostate cancer cells with purified SAC-Par-4-GFP significantly delayed the onset of
tumor in a syngeneic rat prostate cancer model. Taken altogether, we proclaim that
plant made SAC-Par-4 may become a useful alternate therapy for effectively alleviating
cancer in the new era.
Keywords: fusion protein, SAC domain of Par-4, transgenic plant, glycosylation, molecular farming, apoptosis
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Introduction
Prostate cancer is the second most common cause of cancer and
the sixth leading cause of cancer death among men worldwide
(Ferlay et al., 2010; Siegel et al., 2014). Prostate cancer is
associated with the inability of prostatic epithelial cells to
undergo apoptosis rather than with enhanced cell proliferation.
Spontaneous metastasis of tumors from the primary site to
distant tissues causes mortality in advanced cancer patients
(Cooperberg et al., 2009).
Prostate apoptosis response-4 (Par-4) protein (340 amino
acids) is capable of promoting apoptosis in cancer cells and
causes regression of tumors in animal models (Gurumurthy
and Rangnekar, 2004). The Par-4 protein is ubiquitously
expressed in numerous tissues among various species, encoded
by pro-apoptotic Par-4 gene located on human chromosome
12q21, rat chromosome 7q21, and mouse chromosome 10D1
(Johnstone et al., 1996; El-Guendy and Rangnekar, 2003). It
is a multi-domain protein that is structurally segmented into
leucine-zipper domain (LZ) at the carboxyl terminal region,
two nuclear localization sequences (NLS1, NLS2), a nuclear
export sequence (El-Guendy et al., 2003) and a unique SAC
(Selective for Apoptosis of Cancer Cells) domain including
the NLS2 domain (Hebbar et al., 2012). Sells et al. (1994)
identified Par-4 as an immediate early apoptotic gene through
differential hybridization screening of rat AT-3 androgen
dependent prostate cancer cell line exposed to ionomycin for
the induction of apoptosis. Consistent with its pro-apoptotic
function, Par-4 is found to be frequently deleted in pancreatic
and gastric cancer (Kimura and Gelmann, 2000; Boehrer et al.,
2001), down-regulated in renal-cell carcinomas (Cook et al.,
1999), neuroblastoma (Kogel et al., 2001), acute lymphoblastic,
leukemia, chronic lymphocytic leukemia (Boehrer et al., 2001),
endometrial cancer (Moreno-Bueno et al., 2007), and silenced
in endometrial cancer cell lines SKUT1B and AN3CA (Moreno-
Bueno et al., 2007).
Interestingly, a 59 amino acid long SAC domain (amino acid
coordinates 137–195 in rat Par-4; and 145–204 in human Par-
4, respectively) of Par-4 is effective in inducing apoptosis in
cancer cells. This domain is 100% conserved in human, rat, and
mouse homologs (El-Guendy and Rangnekar, 2003). The SAC
domain of Par-4 is the main functional unit for the induction
of apoptosis in cancer cells (El-Guendy et al., 2003) and its
activity depends on its nuclear entry and phosphorylation at
Threonine 155 (Zhao and Rangnekar, 2008). Whole Par-4 and
its SAC domain (SAC-Par-4) both can induce apoptosis through
intrinsic and extrinsic pathways (Burikhanov et al., 2009; Hebbar
et al., 2012). Overexpression of Par-4 or SAC domain induces
apoptosis in different cancer cell lines but does not kill normal
cells in cell culture studies (Burikhanov et al., 2009). In animal
model, systemic overexpression of Par-4 is shown to inhibit
tumor growth and metastasis (Zhao et al., 2011). A previous
study have shown that the full-length Par-4 interacts with Akt1
(cell survival kinase) through LZ domain to confer cancer cells
resistant to apoptosis; however, SAC-domain lacking LZ domain
could escape binding to Akt1 and can potentially kill cancer
cells (Goswami et al., 2005). The ability of SAC-domain to
induce apoptosis in diverse cancer cells can be exploited as
potential anti-cancer regimen to induce tumor suppression via
apoptosis. Thus SAC-Par-4 is gaining world-wide attention as
an effective anti-cancer therapeutics; implying necessities for
high-scale production of biologically active SAC-Par-4 protein.
Molecular farming of essential therapeutics/drug molecules
in plants have several advantages over their conventional
production in bacteria, yeast, or cultured animal or human cell
lines (Goldstein and Thomas, 2004; Ko et al., 2005; Ma et al.,
2005a,b,c; Daniell, 2006; Fox, 2006; Gleba et al., 2007). These
studies clearly demonstrated that transgenic plants could become
an effective expression system for profitable production of plant-
made products (PMP; Goddijn and Pen, 1995; Daniell et al.,
2001). Besides, plant ensures hygienic pharmaceutical production
avoiding harmful or lethal contaminants like viruses, toxins,
prions, oncogenes (Boehm, 2007).
In the present study, we reported the expression of SAC-
Par-4-GFP in transgenic tobacco plants under the control of
modified full-length transcript promoter (M24) of the Mirabilis
mosaic virus. Furthermore, the SAC-Par-4-GFP was fused with
translational enhancer sequence (5′ AMV), apoplast targeting
sequence (aTP) to increase the transgene stability in plant and
to direct the protein into the secretory pathway and, finally,
into the apoplast. The stability and functionality of plant-
derived SAC-Par-4-GFP was confirmed by different molecular
analysis. Alongside, retention to the endoplasmic reticulum
(ER) was achieved by adding an ER retrieval signal (SEKDEL)
to the C-terminus of the apoplast-targeted SAC-Par-4-GFP
construct and transiently expressed in tobacco plant to obtain
a glycosylated and proteolytically stable protein. The proteolytic
stability of transgenic plant-derived recombinant SAC-Par-4-
GFP and transiently expressed SAC-Par-4-GFP-SEKDEL was
compared with bacterial SAC-Par-4. Cancer-specific effectiveness
and bioactivity of plant-made SAC-Par-4-GFP was confirmed by
mammalian cell proliferation assays in PC3, MAT-LyLu, LNCaP
prostate cancer cells lines, and HEK293 non-cancerous cells
along with apoptosis induction in PC3 and NF-κB suppression
activities in PC3, MAT-LyLu, and HEK293 cells. Moreover, the
onset of tumor by MAT-LyLu cells pre-treated and co-injected
with SAC-Par-4-GFP was studied in Copenhagen rats. Our
present findings lay a foundation regarding the anti-prostate
cancer activity of plant-derived SAC-Par-4 and hence SAC-Par-
4 could become an effective plant-made biologics in controlling
prostate cancer. This is a nascent report demonstrating
the inhibitory properties of plant-derived SAC-Par-4-GFP on
prostate cancer cells’ growth.
Materials and Methods
Construction of Chimeric Gene Constructs for
Plant Transformation
The rat Par-4-SAC domain (GenBank accession no U05989) was
fused with GFP to generate SAC-Par-4-GFP recombinant DNA
fragment. This sequence was then codon-optimized forNicotiana
tabacum. A 35-nucleotide long 5′-untranslated region of AlMV
RNA 4 (5′ AMV; translational enhancer) and apoplast targeting
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sequence (aTP) of Arabidopsis 2S2 protein gene (Kroumova
et al., 2013) were fused with the normalized coding sequence
of SAC-Par-4-GFP. The recombinant sequence thus generated
was synthesized by GeneArt (Invitrogen, Life technologies,
USA1) and cloned into XhoI and SstI sites of the binary vector
pKM24KH (GenBank accession HM036220) carrying modified
full-length transcript promoter (M24) of the Mirabilis mosaic
virus (Dey and Maiti, 1999a,b) to generate the plasmid pKM24-
SAC-Par-4-GFP. The pKM24-GFP construct was also generated
and used as vector control. The physical map of different
structural components and respective restriction sites of different
constructs are represented in Figure 1.
Development of Transgenic Tobacco Plants
Ten independent T0 transgenic plant lines expressing pKM24-
GFP and pKM24-SAC Par-4-GFP were raised following protocol
described earlier (Kumar et al., 2011; Sahoo et al., 2014b; Patro
et al., 2015). Subsequently, segregation analysis for T1 seeds
from each independent line was performed following earlier
protocol (Patro et al., 2015). Seeds from T1 plants showing
appropriate segregation ratios (KanR:KanS = 3:1) were selected
1http://www.lifetechnologies.com/GeneArt/
and respective T2 transgenic plants were raised and maintained
in green-house condition.
Green Fluorescent Protein (GFP) Assay
Total protein from leaves of 8-week-old transgenic pKM24-
SAC-Par-4-GFP (L1–L10) and pKM24-GFP (control plant) was
extracted following earlier protocol (Verwoerd et al., 1995;
Kroumova et al., 2007) and quantified using Bradford (1976)
method where BSA served as standard.
Fluorometric quantification of GFP was done following the
earlier described protocol (Remans et al., 1999; Sahoo et al.,
2014a). The GFP concentration (expressed in μg per mg protein)
was measured in total leaf protein extracts from transgenic and
vector control plants with the Turner Biosystems Luminometer
employing the GFP-UV module using rGFP-S65T (Clontech)
as standard. The results were expressed as means ± standard
deviation of data from five different samples of the same line
(three readings were taken per experiment).
GFP Visualization by Confocal Laser Scanning
Microscopy
The fluorescence images of transgenic tobacco line L3 expressing
SAC-Par-4-GFP were captured with Confocal Laser Scanning
FIGURE 1 | Schematic representation of the constructs. (A) Plant expression vector containing GFP (pKM24-GFP; VC); (B) the synthetic SAC-Par-4 gene
fused in-frame with GFP (pKM24-SAC-Par-4-GFP). LB: left T-DNA border; RB: right T-DNA border; 5′ AMV: a translational enhancer sequence; aTP: the apoplast
targeting sequence of the Arabidopsis 2S2 protein; M24: recombinant full-length Mirabilis mosaic virus promoter, KanR: neomycin phosphotransferase II marker
gene; rbcSE9: the 3′-terminator sequences (terminators) of the ribulose bisphosphate carboxylase small subunit and Nos PolyA: nopaline synthase genes are
shown. The EcoRI, XhoI, NcoI, SalI, SstI, HindIII, BamHI, XbaI, and ClaI restriction sites used to assemble these expression vectors are shown. The Southern and
Northern hybridization probe (SAC-Par-4) is indicated by thick line in (B).
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Microscope (TCS SP5; Leica Microsystems CMS GmbH, D-
68165, Mannheim, Germany) using LAS AF (Leica Application
Suite Advanced Fluorescence) 1.8.1 build 1390 software as
described earlier by Kroumova et al. (2013). GFP expressed
in transgenic plant was excited with an argon laser (30%)
with AOTF for 488 nm (at 40%; Sahoo et al., 2009), and the
fluorescence emissions were collected between 501 and 580 nm
with the photomultiplier tube (PMT) detector gain set at 1150 V.
Integration Assays for GFP, SAC-Par-4, nptII,
and rbcSE9
Genomic DNA (gDNA) from 3-week old T2–seedlings of
10 independent lines expressing pKM24-GFP and pKM24-
SAC-Par-4-GFP individually were extracted following protocol
of Allen et al. (2006). Integration assay for GFP gene was
performed by PCR amplification of gDNA obtained from
each line individually using GFP primer sets (Table 1).
Likewise, integration of SAC-Par-4, nptII, and rbcSE9 genes
were performed in selected transgenic lines L2, L3, L5, and
L6 expressing pKM24-SAC-Par-4-GFP along with pKM24-GFP
(VC) in presence of respective gene specific primer sets (Table 1).
The PCR amplifications of the above-mentioned genes were
carried out following the standardized protocol (Kumar et al.,
2011).
Southern Blotting
Southern hybridization was carried out according to Sambrook
et al. (1989). Briefly, 10 μg of gDNA isolated from four
transgenic (L2, L3, L5, and L6 of SAC-Par-4-GFP) and vector
control lines were digested overnight with XhoI (Fermentas) at
37◦C, subsequently electrophoresed on 0.8% TAE-agarose and
transferred to a nylon membrane (Hybond-N+, Amersham).
Blotted DNA fragments were hybridized with PCR-amplified
P32-labeled SAC-Par-4 probe using primers listed in Table 1.
TABLE 1 | List of Primers used.
Primer name Primer sequence (5′–3′)
SAC-Par-4-GFP-XhoI Fp GCGGGCCTCGAGCGGATCTTTTTA
SAC-Par-4-GFP-SstI Rp ATGCAGGAGCTCTCACTTGTAAAGC
TCATCCAT
SAC-Par-4-GFP-SEKDEL-SstI Rp ATGCAGGAGCTCTCAAAGCTCATCCTTC
TCGGACTT GTAAAGCTCATCCAT
SAC-Par-4-GFP RT Fp ATGGGTAGAAAGGGAAAGGG
SAC-Par-4-GFP RT Rp AGCCTCATTCTGAATAGTG
SAC-Par-4 probe FP ATGGGTAGAAAGGGAAAGGG
SAC-Par-4 probe RP AGCCTCATTCTGAAT
GFP Fp GATGTTAACGGACACAAGTTCT
GFP Rp CATCATCCTTGAAGAAAATAGTCC
Kan Fp ATGGCAATTACCTTATCCGCAACT
Kan Rp CGCCTTCTTGACGAGTTCTTCTGA
rbcSE9 Fp GCGTCCGGATCCGCTTTCGTTCGTATCAT
CGGTTTC
rbcSE9 Rp ATGTAGTCTAGATGATGCATGTTGTCAA
TCAATTGG
Tubulin Fp ATGAGAGAGTGCATATCGATT
Tubulin Rp TTCACTGAAGAAGGTGTTGAA
Following hybridization at 65◦C for 16 h, the membrane was
washed and subjected to autoradiography.
Transcript Analysis
Total RNA was extracted from 3-week old transgenic tobacco
seedlings expressing pKM24-SAC-Par-4-GFP (L2, L3, L5, and L6)
and vector control line pKM24-GFP using Spectrum Plant Total
RNA kit (Sigma) following the manufacturer’s instructions. Total
RNA was subsequently treated with DNaseI (Sigma) to obtain
DNA free RNA.
Approximately, 10 μg of the above extracted RNA was
subjected to Northern blot analysis as described earlier (Ranjan
et al., 2012). Briefly, total RNA was electrophoresed on 1.2%
(w/v) formaldehyde-agarose gel, blotted onto Hybond-N+
membrane (Amersham), subsequently hybridized with pre-
denatured radiolabeled PCR-amplified P32-SAC-Par-4 probe for
16 h at 60◦C, washed and autoradiographed.
The quantitative accumulation of SAC-Par-4-GFP transcripts
in the above transgenic lines was performed using Real-time
PCR following protocol reported earlier (Ranjan et al., 2012).
Quantitative Real-time PCR was carried out using 5X HOT
FIRE pol Eva Green qPCR Mix plus (ROX) employing Real-
time PCR machine (MJ Research, Bio-Rad; Model; CFD-3220).
The SAC-Par-4 mRNA levels in different transgenic plants were
expressed as fold excess in comparison to the mRNA level of
tubulin. The fold difference in the transcript levels of SAC-Par-4
in comparison to that of tubulin in different transgenic plants was
presented as the mean of three independent biological replicates
with respective standard deviation (SD).
Nuclei Isolation and Nuclear Run-on Assay
Nuclei from 4-week-old tobacco leaves (6 g) of different SAC-Par-
4-GFP transgenic lines namely L2, L3, and L5 and wild tobacco
plant were isolated and nuclear run-on assay was performed
following the protocol described earlier (Folta and Kaufman,
2006). Briefly, 60 μg of the isolated nuclei from individual
plants was incubated in nuclear transcription buffer containing
100 μCi of [α- 32P] UTP (6,000 Ci m/mol), 37.5 units of RNasin
(Promega) and incubated at 30◦C for 30 min. Subsequently,
the mixture was extracted by phenol: chloroform: isoamyl
alcohol (25:24:1), purified and used as a probe for hybridization
(approximately 2 × 106 cpm). PCR amplifications of SAC-Par-4
gene, nptII gene, 18S rRNA (positive control) were carried out
using specific set of primers (Table 1). Approximately, 500 ng
of PCR products along with pBSK plasmid (negative control)
were bound with Hybond-N+ nylon membrane (GEHealth Care
AmershamHybondTM- XL) using dot-blot apparatus. Membrane
was cut into four different strips and each strip was hybridized
with heat denatured radiolabel transcripts obtained from each
lines separately (SAC-Par-4-GFP lines L2, L3, L5, and wild
tobacco plant) for 24 h at 65◦C. Membranes were washed and
autoradiographed.
Enzyme Linked Immunosorbent Assay (ELISA)
and Western Blot Analysis of Transgenic Plants
Total proteins from 6-week-old transgenic tobacco plant under
lines L2, L3, L5, L6, and VC were extracted as described above
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(under GFP assay section). Approximately an aliquot of 5 μg
of respective proteins were used to perform Enzyme linked
immunosorbent assay (ELISA) following protocol described by
Vazquez et al. (1996). The relative accumulation of SAC-Par-4
protein in transgenic lines was estimated according to Patro et al.
(2015). Briefly, total protein samples obtained from transgenic
seedlings expressing SAC-Par-4 and VC were coated on a 96-well
microtiter plate and incubated with primary antibody specific to
PAR-4 (R-334, Santa Cruz) for 2 h. Subsequently after two rounds
of washing, horse-radish peroxidase conjugated secondary
antibody was added. After incubation for 1 h, the plate was
washed twice followed by addition of ortho-phenylenediamine
substrate. The color development was measured at 492 nm in a
microplate reader (Bio-Rad 3550) and converted as a percentage
of total extracted protein by reference to an ELISA standard curve
constructed with the bacterial purified SAC-Par-4 (described
below).
Aliquots of 10 μg of total plant protein extracts obtained
from L2, L3, L5, L6, and VC lines (as described earlier) were
resolved on 12% SDS-PAGE, and electrophoretically transferred
onto a 0.2-μm polyvinylidene difluoride (PVDF) membrane for
Western blot analysis. The primary and secondary antibodies
used are discussed above. The blot was visualized by ECL
chemiluminescence (GE healthcare, UK). β-actin was used as a
loading control.
Construction of Chimeric Gene Construct for
Transient Assay
A plant expression vector, pKM24-SAC-Par-4-GFP-SEKDEL was
constructed that targeted SAC-Par-4-GFP to the ER. Retention
to the ER was achieved by adding an ER retrieval signal
(SEKDEL) to the C-terminus of the apoplast-targeted SAC-Par-
4-GFP construct. Description of the construct is similar to that
pKM24-SAC-Par-4-GFP given in the “Materials and Methods”
section. The physical map of the above construct is given in
Supplementary Figure S1.
Agrobacterium-mediated Transient Expression
Assays
Agrobacterium tumefaciens strain C58C1: pGV3850 was
transformed with pKM24-SAC-Par-4-GFP-SEKDEL construct
using freeze-thaw method. Agrobacterium harboring the above
construct was used to infiltrate the leaves of 10–14-week-old
N. tabacum following the protocol described earlier (Kapila et al.,
1997; Yang et al., 2000). Seventy two hours post-infiltration,
the agro-infiltrated tobacco leaves were processed for protein
extraction. The concentration of SAC-Par-4-GFP-SEKDEL was
quantified using a sandwich ELISA as described before. To
confirm the integrity of transiently expressed SAC-Par-4-GFP-
SEKDEL, Western blot analysis was performed on the protein
extracts with anti-Par-4 antibody.
Deglycosylation Assay
Protein extracts obtained from transgenic plant (line L3)
expressing SAC-Par-4-GFP and transiently expressed SAC-Par-
4-GFP-SEKDEL were digested with the deglycosylating enzyme
PNGase F, EndoH, and O-glycosidase (New England Biolabs;
NEB) for 3 h at 37◦C, according to the manufacturer’s
instructions. Control samples were treated the same, except that
no enzyme was added. To check the O-linked glycosylation
status of SAC-Par-4-GFP and SAC-Par-4-GFP-SEKDEL, the
plant extract was treated with Neuraminidase (NEB), and the
proteins were denatured prior to deglycosylation treatment
with O-glycosidase. All treated samples were then subjected to
Western blot analysis using the anti-PAR-4 antibody.
Bacterial Purification of SAC-Par-4
The 59 amino acid (aa 137-195) long rat SAC-Par-4 was cloned in
pET-29b vector (Novagen) and expressed in BL21 (DE3); purified
through HisPurTM Cobalt resin (Thermo Scientific) as described
earlier (Sahoo et al., 2014a). The purified SAC-Par-4 was dialyzed
and concentrated with a centrifugal filter device (Amicon 10
KDa cut-off), and quantified by Bradford (Sigma). Fractions were
collected and analyzed on 18% SDS-PAGE.
Proteolysis Assays by Trypsin
The protection assays of plant-derived SAC-Par-4-GFP (from
transgenic line L3), SAC-Par-4-GFP-SEKDEL (transiently
expressed) and SAC-Par-4 (bacterial purified) against trypsin
digestion was performed according to Tremblay et al. (2011)
and Wang et al. (2008). Aliquots of 10 μL protein extracts were
removed at various time intervals and boiled for 10 min in
1x SDS-sample buffer, resolved on a 12% SDS-PAGE gel and
subjected to Western blot analysis with the anti-PAR-4 antibody
in the above assay.
Partial Purification of Plant-derived SAC-Par-4
Approximately, 50 g of leaves obtained from transgenic tobacco
plant line L3 expressing SAC-Par-4-GFP were powdered using
liquid nitrogen and homogenized in 150 ml of 1x PBS buffer
supplemented by 5 mM EDTA, 1 mM PMSF and 1.5% PVP-40
and subjected to 20% ammonium sulfate cut. The supernatant
obtained was dialyzed against 50mMTris-HCl (pH 8.0) buffer for
24 h at 4◦C and adjusted to 40% ammonium sulfate saturation;
centrifuged at 30,000 × g for 40 min. The enriched SAC-Par-4-
GFP fraction was obtained as pellet. The pellet was solubilized
and dialyzed twice against water and once against antibody
affinity column buffer consisting of 20 mM Tris-HCl pH 7.0
and 250 mM NaCl at 4◦C. Enriched SAC-Par-4-GFP was further
purified according to the protocol of Downing et al. (2006).
The insoluble materials were removed by centrifugation at
30,000 × g for 20 min at 4◦C and the supernatant was loaded
onto Affi-Gel antibody affinity column (Bio-Rad) in a cold room.
The polyclonal anti- Par-4 antibody (R-334; Santa Cruz) was
combined with an equal volume of Affi-Gel 15 (Bio-Rad) and
mixed at 4◦C for 2 h according to the manufacturer’s instructions.
Protein was eluted in antibody elution buffer (50 mM sodium
citrate pH 4.0, 2 M NaCl) and extensively dialyzed in 1x PBS
and concentrated with a centrifugal filter device (Amicon 10 KDa
cut-off).
Cell Culture and Cell Lines
Hormone-independent PC3 (human) and MAT-LyLu (Rat)
prostate cancer cell lines were cultured in RPMI (Pan Biotech)
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and DMEM (Pan Biotech) media, respectively. Hormone-
dependent LNCaP (human) cells were maintained in RPMI
medium. Non-cancerous HEK293 (human embryonic kidney
cells) was cultured in DMEM. All the media were supplemented
with 10% heat-inactivated fetal bovine serum, 100 U/ml penicillin
(Sigma) and 100 μg/ml streptomycin (Sigma). The cells were
incubated at 37◦C in a humidified atmosphere of 95% air and 5%
CO2.
Cell Viability Assay
Cell viability was determined by the colorimetric MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide) assay
according to Acharya et al. (2014). Briefly, 2 × 103 cells (PC3,
MAT-LyLu, LNCaP, and HEK293) were treated with purified
SAC-Par-4-GFP and VC protein in different concentrations for
48 h. Subsequently MTT was added, incubated in dark for
30 min and the absorbance was measured at 570 nm using an
ELISA reader (Synergy HT, BioTek Instruments Inc., Winooski,
VT, USA). The cell-viability was expressed as percentage
of control cells and average cell-viability was presented as
a mean of three independent experiments with respective
standard deviation. All the experiments were performed in
triplicate.
AnnexinV-FITC and PI Staining
PC3 and HEK293 cells were treated with SAC-Par-4-GFP
(50 ug/ml) and VC (60 ug/ml) protein separately for 48 h.
After treatment, annexinV-FITC and PI staining was performed
as per the protocol described in the kit (Alexa Fluor R©
488 annexin V/Dead Cell Apoptosis Kit, Invitrogen). Stained
cells were analyzed on BD LSRFortessaTM cell analyzer and
the resulting fluorescence was taken by FLH-1 channel for
green fluorescence and FLH-2 channel for red fluorescence.
AnnexinV-FITC-positive and PI-negative cells were considered
as early apoptotic cells (Q2) while those positive for both
annexinV-FITC and PI were considered as late apoptotic
cells (Q4).
Cell Cycle Analysis
SAC-Par-4-GFP and VC protein treated cells (mentioned above)
were processed as per the protocol described in the kit (Tali R©
Cell Cycle Kit, Invitrogen). The cell cycle analysis was performed
on the Tali R© Image-Based Cytometer and results were reported
as percentage of sub-G0 (sub-genomic DNA), G0/G1, S and
G2/M cells. The percentage of total cells in Sub-G0 fraction was
considered as apoptotic fraction.
Transduction of Luciferase Lentivirus and
NF-κB Reporter Assay
Stable NF-κB luciferase reporter cells (PC3-NF-κB-luc, MAT-
LyLu-NF-κB-luc and HEK293- NF-κB-luc) were generated using
ready-to-transduce replication incompetent lentiviral particles as
suggested by Cignal Lenti NFκBReporter (luc) Kit (Qiagen). Cells
were transduced with lentiviral particles at the multiplicity of
infection (MOI) 50 and puromycin (1 μg/ml for PC3, HEK293,
and 8 μg/ml for MAT-LyLu) was used for selection of stably
transduced cells (Jain et al., 2015). The aforementioned lentiviral
particle related works were done with the prior permission
of Institutional Biosafety Committee, Institute of Life Sciences,
Bhubaneswar.
For luciferase assay, 1× 103 cells were seeded in 96- well plate,
grown for 24 h and treated with non-cytotoxic concentration of
SAC-Par-4-GFP in the presence of TNF-α (10 ng/ml) for 6 h.
Cells were lysed and luciferase expression was estimated using
reporter assay kit (Promega, USA). The activity was normalized
with protein concentration from each sample.
Detection of Cleaved Caspase-3 and Cleaved
PARP by Western Blotting
PC3 cells were treated with SAC-Par-4-GFP at different
concentrations for 48 h and Western blot was performed
as described earlier (Plante et al., 2013). Briefly, 40 μg of
protein from each sample were resolved on 10% SDS-PAGE,
electrophoretically transferred onto a PVDF membrane and
incubated with specific anti-caspase-3 (Cell Signaling) and anti-
PARP antibody (Cell Signaling). Anti-rabbit-HRP-conjugated
antibody (Santa Cruz) was used as secondary antibody and
visualized by ECL chemiluminescence (GE healthcare, UK).
β-actin was used as a loading control.
In Vivo Experiment
Animal experiments done in our study were conducted as per
the animal ethics guidelines and were approved by animal ethics
committee of the Institute of Life Sciences (ILS), Bhubaneswar.
As we have used MAT-LyLu prostate cancer cell for our in vitro
study, therefore, we adopt MAT-LyLu rat syngeneic prostate
cancer model for our in vivo validation (Chang et al., 1993;
Jiang et al., 2004). MAT-LyLu cells were harvested from sub-
confluent culture by a brief exposure to 0.25% trypsin and 0.02%
EDTA. After neutralizing trypsin with 10% FBS, the cells were
washed, counted and resuspended in PBS containing SAC-Par-
4-GFP or VC protein at a concentration of 20 μg/100 μl. All
the tubes had a concentration of 0.5 × 106 viable cells/100 μl.
Before injecting the cells into the animals, all the cells were
incubated at room temperature for 30 min. To avoid potential
bias, the tubes containing cells (treated with different proteins)
were coded as T1 (SAC-Par-4-GFP) and T2 (VC) and injected
by an individual unaware of the nature of samples. Aliquots
of 100 μl of cell suspension (0.5 × 106 cells) were injected
subcutaneously into the flank region of six different male
Copenhagen rats (n = 3 for each group). Measurement of the
tumor volumes in each rat were conducted between 10th day
and 18th day post-injection. Tumor volume was calculated by
using formula V = (W2 × L)∗0.52 for caliper measurements,
where V is tumor volume,W is tumor width, and L is the tumor
length. On day 18 post injection, all the animals were sacrificed
for evaluation. Following this, tissues were preserved in 10%
formalin, embedded in paraffin, sectioned (5 μm in thickness)
and subjected to hematoxylin and eosin (H&E) staining (Sahoo
et al., 2008).
Statistical Analysis
Statistical analysis of all the data were performed adopting
Student’s t-test (using Graph Pad Prism version 5.01) and
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presented as a mean of three or four independent experiments.
The p-value of less than 0.05 was considered significant.
Results
Design and Construction of In Planta
Expression Cassette and Generation of
SAC-Par-4-GFP Expressing Transgenic
Tobacco Plants
We designed two primary plant expression cassettes namely
pKM24-SAC-Par-4-GFP and pKM24-GFP for this study. The
pKM24-GFP was used as vector control (VC) while the other
directs the expression of SAC-Par-4-GFP in plants under the
control of the modified full-length M24 transcript promoter
of the Mirabilis mosaic virus (Figure 1). The pKM24-GFP and
pKM24-SAC-Par-4-GFP were used to generate transgenic plants
(Nicotiana tabacum cv. Samsun NN).
Analysis of Transgenic Tobacco Plants
GFP-integration in all 10 independent pKM24-GFP and
pKM24-SAC-Par-4-GFP T2 transgenic plants was confirmed by
GFP (250 bp) amplification using PCR as described earlier
(Figure 2A). Further, we detected enhanced GFP protein
accumulation in the transgenic lines L1, L2, L3, L6, L7, and L10
(Figure 2B). Independent transgenic lines L2, L3, L5, and L6 were
selected for further analysis. In this study, wild-type plants and
the vector control-GFP plants were used as controls.
Furthermore, we confirmed the integration of 183 bp long
SAC-Par-4 in L2, L3, L5, and L6 transgenic pKM24-SAC-Par-
4-GFP plant but not in pKM24-GFP (VC) plant (Figure 3A).
We also demonstrated integrations of different components of
expression cassette by PCR- amplification of rbcSE9 and nptII in
the above plant lines (Figure 3A).
For Southern blot analysis, the genomic DNA from transgenic
lines L2, L3, L5, L6, and VC was digested with the restriction
enzyme XhoI. The selection of this enzyme is based on the fact
that it digests the genomic DNA with reasonable frequency, but
acts as a single cutter for transgene construct (not inside the SAC-
Par-4 gene; Figure 1B). Southern analysis confirmed integration
of the SAC-Par-4 transgene in the genome of L2, L3, L5, and L6
transgenic lines; we observed higher copy number for L2 line in
comparison to the other lines. Overall, appearance of discrete and
alike Southern positive bands (from different transgenic lines)
suggests that integration of SAC-Par-4 is in tandem fashion in
plant genome, indicating independent nature of transgenic events
(Figure 3B).
Alongside, Northern analysis, as describes earlier, yielded a fair
signal for the presence of SAC-Par-4 transcripts in L2, L3, L5, and
L6 lines harboring pKM24-SAC-Par-4-GFP, while no signal was
detected in pKM24-GFP plant. We observed variations in signal
intensities of Northern bands among different lines (Figure 3C);
with highest expression in line L3. This observation support the
data obtained from Real-time RT-PCR experiment. We observed
expression of SAC-Par-4-GFP transcripts in following order:
L3 > L5 > L2 > L6 (Figure 3D).
We performed nuclear run-on assays using intact nuclei
isolated from L2, L3, and L5 lines to measure the accumulation
of SAC-Par-4-GFP transcripts in vivo and to analyze potential
differences in the transcription initiation between the transgenic
lines. Data obtained revealed that SAC-Par-4, nptII, and 18S genes
were expressed in above lines, with the strongest transcription
rate found in L3 line which is supporting the result obtained from
Northern blot and Real-time assays (Figure 3E).
ELISA and Western Blot Analysis of
Plant-derived SAC-Par-4-GFP
The accumulation level of recombinant SAC-Par-4-GFP in
different transgenic lines (L2, L3, L5, and L6) was evaluated
by ELISA as described earlier. We noticed SAC-Par-4-GFP
accumulation levels varied among independent transgenic plants
(T2) ranging from 0.05% to 0.15% total soluble protein or
1.6–10.5 μg /g fresh leaf weight (results not shown in detail).
The L3 line displayed maximum recombinant SAC-Par-4-
GFP accumulation (0.15%) as compared to L2, L5, and L6
(Figure 4A). The expression of ER-targeted SAC-Par-4-GFP-
SEKDEL in infiltrated leaves reached the highest level at day 3
post-infiltration (dpi), with yields upto 88 μg/g fresh weight.
In continuation, we carried out Western blot analysis to check
the integrity of the plant-derived SAC-Par-4-GFP as described
earlier and observed a band of around 32 kDa SAC-Par-4-GFP
protein on the blot from L2, L3, L5, and L6 tobacco plants
(Figure 4B).
Deglycosylation Analysis of Plant-derived
SAC-Par-4-GFP
We performed deglycosylation assays on the protein extracts
obtained from transgenic line L3 expressing SAC-Par-4-GFP
and found that the apoplast-targeted SAC-Par-4-GFP was fully
resistant to endoglycosidase H (EndoH) digestion (Figure 5A,
lanes 1 and 2) and peptide N-glycosidase F (PNGaseF) treatment
(Figure 5A, lanes 3 and 4), suggesting that SAC-Par-4-GFP does
not have any glycan molecules sensitive to both of these enzymes.
In parallel, the efficacies of these enzymes (Endo H and PNGase
F) were validated by digestion of a different plant- derived
protein namely human peroxisomal 2,3-enoyl CoA isomerase
protein HsPECI2 (Rai et al; unpublished data from our group).
Furthermore, enzymatic treatment with α-neuraminidase and
O-glycosidase followed by Western blot analysis with anti-PAR-4
polyclonal antibody displayed no band shift for apoplast-targeted
SAC-Par-4-GFP protein extract demonstrating that SAC-Par-4-
GFP was resistant toO-glycosidase treatment (Figure 5B). Taken
together, these results indicate plant-derived apoplast-targeted
SAC-Par-4-GFP is not glycosylated.
Furthermore, deglycosylation analysis was performed with the
total protein extracts obtained from agroinfiltrated tobacco leaves
expressing ER-targeted SAC-Par-4-GFP-SEKDEL as described in
the Section “Material and Methods.” Data obtained revealed
plant-derived SAC-Par-4-GFP-SEKDEL was resistant to both
PNGase F and Endo H (Figure 5C). Interestingly, O-glycosidase
treatment followed by Western blot analysis displayed a new
smaller band with a molecular mass of approximately 32 kDa in
O-glycosidase treated SAC-Par-4-GFP-SEKDEL protein extract
Frontiers in Plant Science | www.frontiersin.org 7 October 2015 | Volume 6 | Article 822
Sarkar et al. Functional characterization of plant-derived SAC-Par-4
FIGURE 2 | Green Fluorescent Protein (GFP) analyses in transgenic tobacco lines. (A) PCR amplification of GFP (250 bp) using genomic DNA isolated from
10 independent transgenic plants (T2 generation) expressing SAC-Par-4-GFP, vector control (VC) plant and wild-type plant; (B) The GFP protein concentration
(expressed as μg GFP/mg protein) was measured in total soluble protein of transgenic and wild-type plants using Turner Biosystems Luminometer at GFP-UV
module. Error bars indicate the standard deviation of readings from five different plants of each line (three readings per plant).
compared to the untreated sample which migrated around
34 kDa (Figure 5D). Hence, the SEKDEL-tagged SAC-Par-4-GFP
proteins were sensitive to O-glycosidase, suggesting presence
of O-linked glycans indicative of ER localization with efficient
retention or retrieval from the cis-Golgi.
Proteolytic Stability of Plant-derived
SAC-Par-4-GFP
Trypsin digestions were carried out with total protein extract
obtained from plant-derived SAC-Par-4-GFP, SEKDEL-tagged
SAC-Par-4-GFP and bacterial purified SAC-Par-4 as described in
Section “Material and Methods” (Figure 6 and Supplementary
Figure S2). To evaluate the resistance or sensitivity of
these proteins toward trypsin digestion, Western blot analysis
was performed with anti-Par-4 antibody by taking various
aliquots of the trypsin-treated protein extracts at different
time points (0, 1 min, 5 min, 15 min, and 30 min). The
applied trypsin ratio to recombinant proteins was 40:1 and
10:1 (w/w) for plant extract and bacterial purified protein,
respectively; Result of Figure 6 confirmed that plant-derived
SAC-Par-4-GFP was resistant to trypsin digestion even after
15 min post-treatment while Escherichia coli derived SAC-Par-
4 got degraded within 10 min of incubation. Furthermore,
approximately 90% of SAC-Par-4-GFP-SEKDEL remained intact
after 30 min of incubation (Supplementary Figure S2). The
enhanced stability of ER-targeted SAC-Par-4-GFP-SEKDEL
could be attributed to the fact that this protein is getting
effectively glycosylated. This result demonstrated that plant-
derived SAC-Par-4-GFP showed enhanced protection to trypsin
digestion.
Purification of Plant-derived SAC-Par-4-GFP
Protein
We partially purified SAC-Par-4-GFP from transgenic line L3
by antibody pull-down approach, as described in “Material
and Methods” section. The enrichment coupled with affinity
chromatography process exhibited 50% recovery and above 70%
purification of the SAC-Par-4-GFP as confirmed by SDS-PAGE
and Western blot (Figure 7).
Plant-derived SAC-Par-4-GFP Inhibited Cell
Growth, Induced Apoptosis In Vitro and
Delayed the Onset of Tumor Growth In Vivo
The biological activity of plant-derived partially purified SAC-
Par-4-GFP from L3 line was determined by MTT assay on PC3,
MAT-LyLu, and LNCaP cell lines at different concentrations
(10, 20, 30, 40, 50, and 60 μg/ml) for 48 h as described
earlier. The viability of PC3 and MAT-LyLu cells were reduced
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FIGURE 3 | Transgenic analyses. (A) PCR amplification of different genes, viz. SAC-Par-4 (i); rbcSE9 (ii) and nptII (iii) from transgenic lines VC, L2, L3, L5, and L6
on 1.5% agarose gel; (B) Southern blot analysis to investigate SAC-Par-4 gene insertion in transgenic plant lines VC, L2, L3, L5, and L6. Underneath is the agarose
gel picture showing XhoI digested genomic DNA (10 μg) of T2 generation of four transgenic (L2, L3, L5, and L6 of SAC-Par-4-GFP) and vector control lines (prior
blotting); (C) Northern blot analysis of SAC-Par-4 mRNA expression in transgenic plants VC, L2, L3, L5, and L6. Underneath is an ethidium bromide-stained gel
showing rRNA quality; (D) Real-time analysis of SAC-Par-4 transcripts in VC, L2, L3, L5, and L6 lines. The data were normalized by tubulin transcripts. The data
shown are mean values from three independent experiments. Bars indicate the standard errors of means; (E) Nuclear run-on assay of SAC-Par-4 transcripts. Dot
blots were hybridized to 32P-labeled nascent transcripts from wild-type plant and transgenic lines L2, L3, and L5 which were synthesized by run-on transcription.
pBSK plasmid (1 μg) and 18S ribosomal DNA (0.5 μg) were used as controls.
with increasing concentration of SAC-Par-4-GFP protein, and
maximum cell death was observed up to 63 and 66%, respectively,
at 60 μg/ml concentrations (Figure 8A). Further, the IC50
values were found to be 43 μg/ml and 50 μg/ml for PC3
and MAT-LyLu cells, respectively. However SAC-Par-4-GFP
exhibited maximum 10–15% growth inhibition in LNCaP cells.
On the other hand, the protein obtained from pKM24-GFP
(VC) showed no cytotoxic effect at 100 μg/ml concentration.
In parallel, we observed plant-derived SAC-Par-4-GFP exhibited
no cytotoxicity on HEK293 cell line, which is non-cancerous in
nature (Figure 8A).
We performed AnnexinV-FITC/PI staining to investigate
whether SAC-Par-4 induces apoptosis in the PC3 cancer cell and
non-cancerous HEK293. As shown in Figure 8B, treatment with
50 μg/ml of SAC-Par-4-GFP for 48 h induced apoptosis in PC3
cells and increased the percentage of early and late apoptotic
cells by approximately fourfold compared to the vector control.
At the same time, in case of HEK293 cell line, there was no
significant difference between the total percentages of apoptotic
cells in vector control and SAC-Par-4-GFP treated cells (data
not shown). Further cell cycle analysis in PC3 cells treated with
SAC-Par-4-GFP protein (50 μg/ml) for 48 h revealed significant
increase in sub-G1 population (sub-diploid DNA fraction) by
4.6 fold compared to the vector control and this population
represented the apoptotic portion, implying SAC-Par-4 promote
apoptosis (Figure 8C). In the same direction, we observed signals
for apoptotic markers like cleaved caspase-3 and cleaved PARP in
PC3 cells treated with 50 μg/ml of purified SAC-Par-4-GFP for
48 h (Figure 8D).
Suppression of NF-κB activity by SAC-Par-4 in PC3-NF-κB-
luc and MAT-LyLu-NF-κB-luc cells was studied as described
earlier. NF-κB luciferase activity was significantly increased in
PC3 cells by approximately twofold and in MAT-LyLu cells by
approximately fourfold in TNF-α-stimulated cells compared with
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FIGURE 4 | Evaluation of recombinant SAC-Par-4-GFP accumulation. (A) ELISA analysis of recombinant SAC-Par-4-GFP accumulation from L2, L3, L5, and
L6 transgenic plants along with wild-type and VC plant. Values are the average of three independent experiments. Bars indicate standard deviations; (B) Detection of
SAC-Par-4-GFP protein on the Western blot from different transgenic lines, indicated by arrow. Numbers on the left indicate the size of protein standard. β-actin was
used as loading control.
the untreated control group. However, the TNF-α-stimulated
luciferase activity was significantly reduced (p < 0.05) to
approximately twofold by 30 μg/ml of SAC-Par-4 treatment in
both cell lines. In parallel, there was no suppression of NF-κB
activity observed in case of TNF-α-stimulated HEK293- NF-
κB-luc cells upon treatment with 30 μg/ml of SAC-Par-4-GFP
(Figure 8E).
In the in vivo study, we have examined the effect of
plant-derived affinity-purified SAC-Par-4 on tumor incidence
in a syngenic rat prostate cancer model. The result from this
investigation indicated that SAC-Par-4-GFP pre-treatment and
co-injection with the MAT-LyLu cells inhibited the rate of tumor
growth in vivo as compared to control group. Visible tumors
appeared at sixth day after the injection of cells pre-treated
with pKM24-GFP vector control protein. Whereas, there was no
visible tumor up to 14th day in animals injected with SAC-Par-
4-GFP pre-treated cells. Moreover, tumor volume measured after
the 10th day of cancer cells and vector control protein injection
showed exponential growth of all the tumors of the control
animals. Further the hematoxylin and eosin (H&E) staining
confirmed the presence of viable cancer cells in all tumor tissues;
alongside the staining ruled out the possibility of non-tumor
(necrotic) mass (Figure 8F).
Discussion
There are several definite advantages of using plants as
bioreactor for large-scale production of recombinant biologics
at cheaper rate and they are capable of imparting post-
translational modification in synthesized protein. We raised
transgenic tobacco plants expressing codon optimized rat SAC-
Par-4-GFP gene under the control of strong constitutive M24
promoter; a constitutive promoter with 25-fold stronger activity
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FIGURE 5 | Deglycosylation analysis of recombinant apoplast-targeted SAC-Par-4-GFP of transgenic line L3 and ER-targeted
SAC-Par-4-GFP-SEKDEL of agroinfiltrated tobacco leaves protein extract. Western blot analysis of (A) SAC-Par-4-GFP protein treated with
endo-β-N-acetylglucosaminidase H (Endo H) and peptide-N-glycosidase F (PNGase F); Western blot analysis of (B) O-glycosidase treated protein extract obtained
from transgenic SAC-Par-4-GFP. Numbers on the left indicate the positions of protein size markers. “+” indicates in presence of enzymes and “–” indicates without
enzymes. Western blot analysis of (C) SAC-Par-4-GFP-SEKDEL protein treated with peptide-N-glycosidase F (PNGase F) and endo-β-N-acetylglucosaminidase H
(Endo H; left); Western blot analysis of (D) O-glycosidase treated protein extract obtained from transiently expressed SAC-Par-4-GFP-SEKDEL. Arrows point to the
deglycosylated form of plant SAC-Par-4. Numbers on the left indicate the positions of protein size markers.
than the CaMV35S promoter (Dey and Maiti, 1999a,b). We
deliberately fused a translational enhancer sequence (5′ AMV)
and apoplast targeting sequence (aTP) of Arabidopsis 2S2
protein gene to ensure stability and enhanced production of
SAC-Par-4 (Schillberg et al., 1999; Benchabane et al., 2008),
(Figure 1). Additionally, for the transient assay we coupled
the SEKDEL signal sequence to the C-terminus of the SAC-
Par-4-GFP to target the recombinant SAC-Par-4-GFP to the
ER lumen for proper post-translational modifications, such as
glycosylation and disulphide bond formation (Supplementary
Figure S1; Hwang et al., 1992; Ma et al., 2005b; Wang et al.,
2008).
Rate of seed germination, segregation analysis (Table 2),
molecular characterization, gene integration and expression
analysis of SAC-Par-4-GFP transgenic lines were performed
(Figures 2–4); based upon the GFP content in the above lines,
we have selected three lines (L2, L3, and L6) with higher GFP
accumulation and one with low GFP content L5 for further
study. The higher accumulation of plant-derived SAC-Par-4-
GFP may be attributed to several factors acting in synergy,
including the stable nature of the protein itself, the use of a
strong M24 promoter coupled with a 5′ AMV–2S2 signal peptide
sequence. We found a strong expression of SAC-Par-4-GFP
both at transcript and protein levels in L3 transgenic plant,
while moderate to weak expression in L2, L5, and L6 transgenic
plants, respectively. Even though, we noted higher copy number
shown by signal obtained in Southern hybridization for L2 line
compared to L3 line, the integration at the heterochromatin
region of the tobacco genome might implicate the silencing
of SAC-Par-4-GFP in L2 line as reported earlier by Xu-Gang
et al. (2002). Furthermore, we found strong GFP expression at
the periphery of guard cells and trichome stalk cell of apoplast
targeted SAC-Par-4-GFP in transgenic line L3 (Supplementary
Figure S3). In lieu of these observations, we finally selected
L3 line for further Affi-gel Par-4 based affinity purification of
SAC-Par-4-GFP.
The major advantage of using plant as a bioreactor is
that it glycosylates the recombinant protein along the
secretory pathway as proteins move from the ER through
the Golgi to their final destination. Therefore, the nature of
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FIGURE 6 | Proteolysis assay. Trypsin digestion of recombinant SAC-Par-4
protein for various time increments and Western blot analysis using anti-Par-4
antibody of (A) apoplast-targeted SAC-Par-4-GFP protein of transgenic line
L3; (B) bacterial derived SAC-Par-4. Each lane contains the starting
equivalent of approximately 500 ng total protein. The position of the molecular
weight marker (M) is indicated.
FIGURE 7 | Purification of plant-derived SAC-Par-4-GFP.
Coomassie-stained 10% SDS-PAGE gel and Western blot showing the partial
purification of SAC-Par-4-GFP from the pKM24-SAC-Par-4-GFP transformed
line L3 along with the enriched fraction. Total soluble protein and eluted
fraction from affinity purification are shown. Arrows indicate molecular size.
glycosylation and proteolytic stability of the apoplast-targeted
SAC-Par-4-GFP and ER-targeted SAC-Par-4-GFP-SEKDEL
protein were analyzed (Figure 5). Glycosylation enhances
the physiochemical properties of a protein by endeavoring
thermal resistance, protection from proteolytic degradation
and stability (Ma et al., 2005c). To attest this preposition, we
targeted SAC-Par-4-GFP protein to the secretory pathway
using apoplast signal sequence and ER-specific SEKDEL
sequence and performed deglycosylation assays as described
previously. Our results indicated that the plant-derived
SAC-Par-4-GFP may contain complex-type N and O-glycans
which were inaccessible to the deglycosylating enzymes
Endo H, PNGaseF, and O-glycosidase which is in accordance
to a previous report for a different plant-derived protein
namely human erythropoietin, EPO (Conley et al., 2009).
In contrast, the SEKDEL-tagged SAC-Par-4-GFP proteins
were sensitive to O-glycosidase (Figure 5D) unlike the
apoplast-targeted SAC-Par-4-GFP (Figure 5B), suggesting
presence of O-linked glycans in ER-targeted SAC-Par-4-GFP-
SEKDEL. Non-glycosylated plant-derived SAC-Par-4-GFP
had almost similar molecular mass (∼32 kDa) to that of
deglycosylated SAC-Par-4-GFP-SEKDEL (∼32 kDa) and had
lower molecular weight to that of the glycosylated SAC-
Par-4-GFP-SEKDEL (∼34 kDa). This is most likely because
of the addition of the ER retention signal motif SEKDEL
to the C-terminus of plant-derived SAC-Par-4-GFP along
with O-linked oligosaccharide chain (Conley et al., 2009). In
silico analysis of SAC-Par-4-GFP-SEKDEL using NetOGlyc
4.0.0.13 software2 affirmed two potential O-glycosylation sites
at positions 20 and 21 located in SAC-Par-4-GFP. Over and
above the recombinant SAC-Par-4-GFP and SAC-Par-4-GFP-
SEKDEL protein showed resistance to trypsin digestion for
15–30 min compared to bacterial derived SAC-Par-4 (Figure 6
and Supplementary Figure S2). This could be explained
by the fact that plant-derived SAC-Par-4 in fusion with
another protein, GFP, is protected against trypsin digestion
as compared to that of bacterial SAC-Par-4. Besides this,
effective glycosylation of SAC-Par-4-GFP-SEKDEL protein
and its enhanced stability could be the other reasons for
increasing the therapeutic value of plant derived SAC-Par-
4-GFP-SEKDEL protein. To achieve higher and more stable
expression, we have begun to produce transgenic tobacco
lines homozygous for the introduced SAC-Par-4-GFP-SEKDEL
gene.
The cytotoxic effect of affinity-purified SAC-Par-4 on PC3 and
MAT-LyLu cells indicates that plant-derived SAC-Par-4 retains
its biological activity (Figure 8A). Importantly, its effect on
both the cancer cells but not on HEK293 cells suggests its
specificity against prostate cancer. Furthermore, the precise role
of plant-derived SAC-Par-4 as a potent anti-prostate cancer agent
needs to be evaluated in reference to its activity against normal
prostate cell lines such as PNT1 A/B or PNT2. An earlier report
(Burikhanov et al., 2009) indicated that normal/immortalized
cells fail to respond to exogenous SAC-Par-4 due to their lower
content of specific cell surface receptor GRP78 in addition to
lack of robust ER-stress response. Moreover, human embryonic
kidney cell line HEK293 has been used as a representative
normal cell line in multiple studies (Imberg-Kazdan et al.,
2013; Zhang et al., 2014; Al-Sheddi et al., 2015; Kim et al.,
2015). HEK293 cells being immortalized and non-cancerous in
nature, have lower expression levels of GRP78 in comparison to
cancer cells which justifies its inclusion as appropriate control
in this study (Li et al., 2008; Burikhanov et al., 2009; Dai
et al., 2010). Apart from evaluating the inhibitory activity of
2http://www.cbs.dtu.dk/services/NetOGlyc/
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FIGURE 8 | Bioactivity of plant-derived SAC-Par-4 in vitro and in vivo. (A) PC3, MAT-LyLu, LNCaP, and HEK293 cells were seeded in 96 well plate, incubated
overnight and treated accordingly with vector control protein (100 μg/ml) or different concentrations (10, 20, 30, 40, 50, and 60 μg/ml) of SAC-Par-4-GFP protein for
48 h. Cell viability was determined by MTT assay and normalized to control for each cell line. The data represented as a mean of three independent experiment,
±SD, n = 3, ∗p < 0.05, ∗∗p < 0.005 and ∗∗∗p < 0.001; (B) PC3 (1 × 106 cells) were treated with vector control protein (100 μg/ml) and partially purified
SAC-Par-4-GFP protein (50 μg/ml), and the percentage of apoptotic cells was analyzed by AnnexinV-FITC/PI staining. Experiment was repeated two times and
quantitative result (Q2 + Q4) is displayed as the mean fold change (±SD) compared with control from two independent experiments; (C) Cell cycle analysis of PC3
cells treated with vector control protein (100 μg/ml) and SAC-Par-4-GFP protein (50 μg/ml). Data are representative of three independent cell cycle analyses and
expressed as a percentages of cells found in different cell population, sub-G1 (apoptotic cells), G0/G1, S, and G2/M; (D) Immunoblot analysis demonstrates cleaved
caspase-3 and cleaved PARP expression in PC3 cells treated with different concentration of SAC-Par-4-GFP protein for 48 h; (E) PC3-NF-κB-luc,
MAT-LyLu-NF-κB-luc, and HEK293-NF-κB-luc reporter cells were treated with TNFα (10 ng/ml) or SAC-Par-4-GFP protein in concentrations of 10, 20, and 30 μg/ml
for 6 h. The results were represented as change in relative luciferase activity, ±SD of three independent experiments and ∗p < 0.05; (F) MAT-LyLu cells pre-treated
and co-injected with SAC-Par-4-GFP protein or vector control protein (20 μg in 100 μl cell suspension) were injected into the flank region of male Copenhagen rats
(n = 3 for each group). After 10 days, tumor volumes were measured every day and plotted. Points in graphics are volume mean values and standard deviations.
H&E staining confirmed presence of viable tumor cells in all the isolated tumor tissues.
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TABLE 2 | Segregation Analyses.
Plant lines Segregation
(KanR:KanS)
%
germination
Showing 3:1
segregation
pKM24-SAC-Par-4-
GFP#1
38R:14S (2.7:1)
30R:12S (2.5:1)
41R:11S (3.7:1)
100%
92%
100%
Yes
pKM24-SAC-Par-4-
GFP#2
37R:13S (2.8:1)
32R:11S (2.9:1)
38R:16S (2.37:1)
98%
100%
96%
Yes
pKM24-SAC-Par-4-
GFP#3
41R:15S (2.73:1)
34R:14S (2.43:1)
34R:13S (2.61:1)
94%
100%
98%
Yes
pKM24-SAC-Par-4-
GFP#4
40R:12S (3.33:1)
38R:16S (2.25:1)
40R:9S (4.44:1)
84%
82%
Yes
pKM24-SAC-Par-4-
GFP#5
32R:21S (1.52:1)
26R:16S (1.62:1)
46% No
pKM24-SAC-Par-4-
GFP#6
33R:13S (2.54:1)
39R:14S (2.78:1)
100%
96%
92%
Yes
pKM24-SAC-Par-4-
GFP#7
27R:12S (2.25:1)
38R:12S (3.2:1)
34R:12S (2.83:1)
94%
100%
92%
Yes
pKM24-SAC-Par-4-
GFP#8
27R:19S (1.42:1)
32R:21S (1.52:1)
74% No
pKM24-SAC-Par-4-
GFP#9
26R:21S (1.24:1)
23R:14S (1.64:1)
76% No
pKM24-SAC-Par-4-
GFP#10
35R:13S (2.69:1)
40R:12S (3.33:1)
36R:14S (2.57:1)
100%
94%
100%
Yes
plant-derived SAC-Par-4 in androgen receptor negative cell lines
like PC3 and MAT-LyLu, we also studied SAC/Par-4 effect in
an AR positive prostate cell line (LNCaP). Plant-derived SAC-
Par-4 showed very low inhibitory effect (10–15% sensitive)
in LNCaP cells. This effect is not significantly higher than
control treatment, which indicates that they could be resistant
or less responsive to induction of apoptosis by plant-made
SAC-Par-4. This is consistent with the findings of Chakraborty
et al. (2001) where the authors described that Par-4 is able
to induce apoptosis in PC3, DU-145, and TSU-Pr cells, while
LNCaP are resistant. Furthermore, the mechanism underlying
the differential cytotoxic effect of plant-derived SAC-Par-4 on
AR positive and AR negative human prostate cancer cells needs
further investigation. The cytotoxic effect of this protein on
both human (PC3) and rat prostate cancer cell lines (MAT-
LyLu) further suggests its efficacy on cancer cells of different
origin, and this might be due to the highly conserved SAC
domain of Par-4 (El-Guendy and Rangnekar, 2003). A similar
kind of effect of Par-4 on cancer cells of multi-species origin
have also been reported earlier (Vetterkind et al., 2005; Shukla
et al., 2013). To rule out the effect of other proteins derived
from the different components of the vector and other soluble
proteins of the plant, we compared the result obtained by purified
SAC-Par-4 protein with the protein obtained from vector control
plant. Our observations from Annexin-V/PI staining, cell cycle
analysis and Western blotting in PC3 cell line (Figures 8B–D)
confirms that plant-derived SAC-Par-4 is able to specifically
kill cancer cell via apoptosis similar to that observed earlier
(Burikhanov et al., 2009). Moreover, the NF-κb luciferase assay
(Figure 8E) clearly demonstrates that plant-derived SAC-Par-
4 is able to significantly suppress the NF-κb activity in both
PC3 and MAT-LyLu cells which is in corroboration to the
previous findings (El-Guendy et al., 2003; Zhao and Rangnekar,
2008).
In the present study, we checked the anti-tumor activity
of plant-derived partially purified SAC-Par-4-GFP by injecting
MAT-LyLu cells pre-treated and co-injected with SAC-Par-4-
GFP or VC protein. We observed visible tumors in case of SAC-
Par-4-GFP pre-treated cells on the 15th day of cells’ injection
(n = 2/3). However, all the animals injected with VC pre-
treated cells had a visible tumor by sixth day of cancer cells
injection (n = 3/3; Figure 8F). The delayed onset in the growth
of tumor in case of SAC-Par-4-GFP pre-treated MAT-LyLu
cells might be due to the fact that pre-incubation with SAC-
Par-4-GFP induced cell-death and at the same time the cells
that escape the cytotoxic effect repopulated to make a visible
tumor at the later time point. Although the animal number
in this study is not so high but we noted a clear visible
difference in the tumor volume developed between SAC-Par-
4-GFP treated and VC protein treated rat groups. A similar
animal cohort (n = 3) has also been used by other investigators
in literature (Moore et al., 2001; Liu et al., 2014). These
observations have encouraged us to check the efficacy of SAC-
Par-4 protein in large animal cohort as a future prospect of
this project. In this regard we have planned to exploit MAT-
LyLu cells labeled with luciferase and implanted orthotopically
in future.
In vitro and in vivo results of our present findings may
be considered as a starting point for ascertaining the anti-
prostate cancer activity of plant-derived recombinant SAC-
Par-4. In order to effectively demonstrate the generalized
cancer-specific efficacy of plant-isolated SAC-Par-4, more and
different robust experiments are required to be performed. These
include evaluation and comparative analysis of anti-tumorigenic
activities of plant-derived SAC-Par-4 in several AR positive cell
lines (LNCaP, LAPC4, and MDA PCa 2b), AR negative cell
lines (PC3, MAT-LyLu, and DU145), normal prostate cell line
(PNT1-A/B, PNT2PrE, and PrS), immortalized human prostate
epithelial cells (PZHPV7) along with detailed studies in a large
cohort of animals. Such vigorous approaches will be required for
further establishing the anti-cancer effect of plant-derived SAC-
Par-4 and also to investigate its possible undesired side-effects on
normal cells.
Taken together, in the current study we have engineered
plant for efficient production and isolation of plant-derived
SAC-Par-4-GFP protein. Importantly, this protein is biologically
active and able to reduce the growth of the prostate cancer cell
lines (PC3 and MAT-LyLu). This cytotoxic effect is potentially
through NF-κb suppression and induction of apoptosis. Our
in vitro and in vivo studies suggest the potential of plant-
derived SAC-Par-4-GFP as a therapeutic agent against prostate
cancer cells; however, further extensive studies are essential to
evaluate the efficacy of this protein in a more clinically relevant
model.
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